Robert B. Huizinga
Chairman chez KANE BIOTECH INC.
Profil
Robert B.
Huizinga is the founder of Renalpro.
He currently holds the position of Executive Chairman at Kane Biotech, Inc. and is a Director at Biovialife, Inc. He is also a Member of Sigma Theta Tau International Honor Society of Nursing, Inc. and serves as the Principal at Reformation Consulting Services, Inc. Previously, he served as an Independent Director at Innovotech, Inc. from 2013 to 2016.
Prior to that, he was the Vice President-Clinical Affairs at Isotechnika Pharma, Inc. from 2002 to 2013.
He also held the position of Executive Vice President-Research at Aurinia Pharmaceuticals, Inc. from 2020 to 2022.
Dr. Huizinga obtained a doctorate degree from Regent University and a graduate degree from the University of Alberta.
Postes actifs de Robert B. Huizinga
Sociétés | Poste | Début |
---|---|---|
KANE BIOTECH INC. | Chairman | 20/02/2024 |
Sigma Theta Tau International Honor Society of Nursing, Inc.
Sigma Theta Tau International Honor Society of Nursing, Inc. Hospital/Nursing ManagementHealth Services Sigma Theta Tau International Honor Society of Nursing, Inc. provides nursing services. The company was founded in 1922 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Biovialife, Inc.
Biovialife, Inc. Miscellaneous Commercial ServicesCommercial Services Biovialife, Inc. operates as a biotechnology intellectual property company. Its products include IMveaIH, IMveaQL and IMveaQT. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
Anciens postes connus de Robert B. Huizinga
Sociétés | Poste | Fin |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 31/10/2022 |
INNOVOTECH INC. | Director/Board Member | 08/11/2016 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Chief Tech/Sci/R&D Officer | 23/10/2013 |
Renalpro | Founder | - |
Formation de Robert B. Huizinga
Regent University | Doctorate Degree |
University of Alberta | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
INNOVOTECH INC. | Health Services |
KANE BIOTECH INC. | Commercial Services |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Sigma Theta Tau International Honor Society of Nursing, Inc.
Sigma Theta Tau International Honor Society of Nursing, Inc. Hospital/Nursing ManagementHealth Services Sigma Theta Tau International Honor Society of Nursing, Inc. provides nursing services. The company was founded in 1922 and is headquartered in Indianapolis, IN. | Health Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
Biovialife, Inc.
Biovialife, Inc. Miscellaneous Commercial ServicesCommercial Services Biovialife, Inc. operates as a biotechnology intellectual property company. Its products include IMveaIH, IMveaQL and IMveaQT. The company is headquartered in Toronto, Canada. | Commercial Services |
Renalpro |